Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The… Recruiting

2022-500966-82-00 Resectable locally advanced squamous cell carcinoma (SC 5 2020-03-11
A randomized, non-comparative, phase II study investigating the best epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) s… Recruiting

2024-518223-29-00 Advanced or metastatic untreated EGFR mutation positive 4 2020-03-10
An Interventional, Phase II, Non Randomized, Mono-centric Study on the Clinical Efficacy and Safety of the Medical Device PAGETEX® as a Phot… Recruiting

2024-514093-41-00 Vulvar Extra Mammary Paget's Disease confirmed by biops 4 2019-08-27
A multi-center phase III randomized study comparing continuous versus fixed duration therapy with Daratumumab, Lenalidomide, and Dexamethaso… Recruiting

2024-511855-16-00 Onco-hematology 5 2019-07-25
Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcyRIIB), in Combination with Rituximab With or Without Acalabrutinib … Recruiting

2024-512972-36-00 Indolent B-Cell Non-Hodgkin Lymphoma 9 2019-05-23
Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy. (SOLSTICE… Recruiting

2024-516180-85-00 Metastatic colorectal cancer 5 2019-04-15
Phase II trial of nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma, for evaluation of response in … Recruiting

2024-516807-17-00 Relapsing/Refractory ALK+ Anaplastic Large cell Lymphom 4 2019-01-02
CLINICAL TRIAL TO EVALUATE BLADDER INSTILLATION OF NEOADJUVANT CHEMOTHERAPY TO TRANSURETHRAL RESECTION OF THE BLADDER FOR THE PREVENTION OF … Recruiting

2024-512683-53-00 Non-muscle invasive bladder cancer 6 2018-05-18
A Phase 3 Trial of Antibody hu3F8 and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in High-Risk Neuroblastoma Patients with Pri… Recruiting

2023-508587-29-00 Treatment of high-risk neuroblastoma patients with prim 4 2018-04-03
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) Recruiting

2024-512358-78-00 Solid Tumors 7 2015-01-20
ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting

2024-512657-24-00 Acute Lymphoblastic Leukaemia 10 2014-03-27
NeoMatryx - Neoadjuvant Merkel cell carcinoma therapy (Tx) with the PD-1 inhibitor Cemiplimab – A randomized, double-blind, placebo-controll… Recruiting

2025-522091-84-00 Merkel Cell Carcinoma 4 2026-05-29
The Efficacy of Pressurised Intraperitoneal aerosol chemotherapy (PIPAC) combined with CURativE intent minimally invasive radical resection … Recruiting

2024-516194-76-00 Gastric adenocarcinoma 4 2026-05-28
Discontinuation Outcome in Multiple Myeloma after BCMA-CD3 treatment Recruiting

2025-524022-18-00 Multiple myeloma 4 2026-05-22
A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and s… Recruiting

2025-521702-18-00 Locally advanced unresectable or metastatic colorectal 1 2026-05-21
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Ponatin… Recruiting

2025-524311-37-00 chronic myeloid leukemia 2 2026-05-19
A Multicenter, Open-Label, Phase 1a/b First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitu… Recruiting

2025-524857-15-00 Advanced Solid Tumors 1 2026-05-19
Fecal Microbiota Transplantation to RESCUE patients with unresectable Hcc progressors to first line therapy with AtezolizUmaB and Bevacizuma… Recruiting

2023-510504-45-00 unresectable hepatocellular carcinoma (HCC) 4 2026-05-14
A Phase 1/2 Study of Pumitamig alone or in Combination with Ipilimumab in First-Line HCC Recruiting

2025-523602-33-00 Advanced or unresectable Hepatocellular Carcinoma (HCC) 9 2026-05-13
A Phase I study to evaluate the safety and dosimetry of imaging with 68Ga-OncoACP3 in prostate cancer. Recruiting

2025-524594-16-00 Patients with prostate cancer with: - suspected metasta 1 2026-05-12
A clinical trial of MK-1084, pembrolizumab, and chemotherapy in people with nonsmall cell lung cancer (MK-1084-013) Recruiting

2024-517337-41-00 Completely resected Stage IIA-IIIB (N2) KRAS G12C mutat 5 2026-05-12
A clinical study of belzutifan and zanzalintinib in people with advanced kidney cancer (MK-6482-034) Recruiting

2024-516993-31-00 Renal Cell Carcinoma 5 2026-05-11
Study of STK-012 Alone and with Other Treatments in Patients with Advanced Lung Cancer and Other Cancers Recruiting

2025-522632-14-00 Non-small cell lung cancer (NSCLC) 4 2026-05-11
A FIH study to investigate the safety and preliminary efficacy of expanded autologous urothelial cells bioprinted during orthotopic neobladd… Recruiting

2025-522963-14-00 Μuscle-invasive bladder cancer (MIBC) patients, eligibl 1 2026-05-09